Australian public assessment report for BNT162b2 (mRNA)

An observation of 12 appendicitis events across both treatment groups is not greater than expected based on background rates (estimated in a US Electronic Health Records database). Up to cut-off date of 14 November 2020, the number of participants who reported SAEs was similar in the two groups (0.7% for the BNT162b2 group versus 0.5% for the ... ................
................